advertisement
Drug Delivery 23
Showing records 1 to 23 | Display all abstracts in Drug Delivery105549 Hyaluronic acid-enriched bilosomes: an approach to enhance ocular delivery of agomelatine via D-optimal design: formulation, characterization, and pharmacodynamic evaluation in rabbits
Nemr AA
Drug Delivery 2022; 29: 2343-2356
105280 Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Zhao Y
Drug Delivery 2022; 29: 613-623
105573 Mimicking chronic glaucoma over 6 months with a single intracameral injection of dexamethasone/fibronectin-loaded PLGA microspheres
Aragón-Navas A
Drug Delivery 2022; 29: 2357-2374
105331 Chitosan-coated bovine serum albumin nanoparticles for topical tetrandrine delivery in glaucoma: and assessment
Radwan SE
Drug Delivery 2022; 29: 1150-1163
105573 Mimicking chronic glaucoma over 6 months with a single intracameral injection of dexamethasone/fibronectin-loaded PLGA microspheres
Rodrigo MJ
Drug Delivery 2022; 29: 2357-2374
105549 Hyaluronic acid-enriched bilosomes: an approach to enhance ocular delivery of agomelatine via D-optimal design: formulation, characterization, and pharmacodynamic evaluation in rabbits
El-Mahrouk GM
Drug Delivery 2022; 29: 2343-2356
105331 Chitosan-coated bovine serum albumin nanoparticles for topical tetrandrine delivery in glaucoma: and assessment
El-Moslemany RM
Drug Delivery 2022; 29: 1150-1163
105280 Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Huang C
Drug Delivery 2022; 29: 613-623
105573 Mimicking chronic glaucoma over 6 months with a single intracameral injection of dexamethasone/fibronectin-loaded PLGA microspheres
Rodrigo MJ
Drug Delivery 2022; 29: 2357-2374
105280 Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Zhang Z
Drug Delivery 2022; 29: 613-623
105573 Mimicking chronic glaucoma over 6 months with a single intracameral injection of dexamethasone/fibronectin-loaded PLGA microspheres
Garcia-Herranz D
Drug Delivery 2022; 29: 2357-2374
105331 Chitosan-coated bovine serum albumin nanoparticles for topical tetrandrine delivery in glaucoma: and assessment
Mehanna RA
Drug Delivery 2022; 29: 1150-1163
105549 Hyaluronic acid-enriched bilosomes: an approach to enhance ocular delivery of agomelatine via D-optimal design: formulation, characterization, and pharmacodynamic evaluation in rabbits
Badie HA
Drug Delivery 2022; 29: 2343-2356
105280 Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Hong J
Drug Delivery 2022; 29: 613-623
105573 Mimicking chronic glaucoma over 6 months with a single intracameral injection of dexamethasone/fibronectin-loaded PLGA microspheres
Martinez T
Drug Delivery 2022; 29: 2357-2374
105331 Chitosan-coated bovine serum albumin nanoparticles for topical tetrandrine delivery in glaucoma: and assessment
Thabet EH; Abdelfattah EA
Drug Delivery 2022; 29: 1150-1163
105573 Mimicking chronic glaucoma over 6 months with a single intracameral injection of dexamethasone/fibronectin-loaded PLGA microspheres
Subias M
Drug Delivery 2022; 29: 2357-2374
105280 Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Xu J
Drug Delivery 2022; 29: 613-623
105573 Mimicking chronic glaucoma over 6 months with a single intracameral injection of dexamethasone/fibronectin-loaded PLGA microspheres
Subias M; Mendez S
Drug Delivery 2022; 29: 2357-2374
105280 Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Sun X
Drug Delivery 2022; 29: 613-623
105331 Chitosan-coated bovine serum albumin nanoparticles for topical tetrandrine delivery in glaucoma: and assessment
El-Kamel A
Drug Delivery 2022; 29: 1150-1163
105280 Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Sun J
Drug Delivery 2022; 29: 613-623
105573 Mimicking chronic glaucoma over 6 months with a single intracameral injection of dexamethasone/fibronectin-loaded PLGA microspheres
Ruberte J; Pampalona J; Bravo-Osuna I; Garcia-Feijoo J; Pablo LE; Garcia-Martin E; Herrero-Vanrell R
Drug Delivery 2022; 29: 2357-2374
